A phase I study of PT-112 in advanced solid tumors.

被引：3
|
作者：
Karp, Daniel D.
Camidge, D. Ross
Bryce, Alan Haruo
Jimeno, Jose
Infante, Jeffrey R.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase I Program, Houston, TX 77030 USA
[2] Univ Colorado Denver, Aurora, CO USA
[3] Mayo Clin, Phoenix, AZ USA
[4] Pangaea Biotech SL, Barcelona, Spain
[5] Sarah Cannon Res Inst, Nashville, TN USA
[6] Tennessee Oncol PLLC, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2519
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors.
    Kim, Edward Jae-hoon
    Semrad, Thomas John
    Gandara, David R.
    Riess, Jonathan
    Li, Tianhong
    Yu, Aiming
    Matsukuma, Karen
    Mack, Philip C.
    Kelly, Karen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] A phase I study of aflibercept, pemetrexed (P), and cisplatin (C) in patients with advanced solid tumors.
    Townsley, C. A.
    Siu, L. L.
    Pedro-Salcedo, M. San
    Liu, L.
    Wakelee, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors.
    Huynh, Jasmine
    Chen, Justin
    Kim, Edward Jae-Hoon
    Gandara, David R.
    Semrad, Thomas John
    Riess, Jonathan W.
    Li, Tianhong
    Wu, Chun-Yi
    Zhang, Chao
    Yu, Aiming
    Matsukuma, Karen
    Kelly, Karen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Phase I clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumors.
    Alexandre, J
    Tchen, N
    Berthault-Cvitkovic, F
    Misset, JL
    Benettaib, B
    Kahatt, C
    Raymond, E
    Weems, G
    MacDonald, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9057S - 9057S
  • [35] Phase I study of docetaxel (D), Carboplatin (C) and etoposide (E) in advanced solid tumors.
    Dunphy, F
    Dunleavy, T
    Cantrell, C
    Visconti, J
    Richart, J
    Pincus, S
    Petruska, P
    ANNALS OF ONCOLOGY, 2000, 11 : 135 - 135
  • [36] Phase I study of pazopanib and ixabepilone in patients with solid tumors.
    Ganesan, Chitra
    Obulareddy, J.
    Bliss, Robin L.
    Dudek, Arkadiusz Z.
    CANCER RESEARCH, 2013, 73 (08)
  • [37] A phase I study of ARRY-520 in solid tumors.
    Goncalves, P. H.
    Sausville, E. A.
    Edelman, M. J.
    Pandya, N. B.
    Houlehan, M. M.
    Freeman, B.
    Simmons, H. M.
    Stallings, J. S.
    Ptaszynski, A. M.
    LoRusso, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [39] Results of phase I clinical trials of Coramsine in patients with advanced solid tumors.
    Millward, M.
    Powell, A.
    Daly, P.
    Tyson, S.
    Ferguson, R.
    Carter, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 96S - 96S
  • [40] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
12345